Zymeworks Inc. logo

Zymeworks Inc.

1937653

Zymeworks is a biotechnology company managing a portfolio of healthcare assets and developing novel, multifunctional biotherapeutics. They focus on optimizing cash flows from licensed products like Ziihera® (zanidatamab-hrii) and supporting early-stage development of innovative medicines. Their therapeutic platforms and integrated drug development engine engineer differentiated antibody-based therapeutics for themselves and partners. They aim to transform areas of high unmet medical need.

86
Mycket Pålitlig
Förtroendepoäng

Officiellt Register

Juridiskt Namn
Zymeworks Inc.
Organisationsnummer
1937653
Momsnummer
883099146
Företagsstatus
Active
Adress
108 PATRIOT DRIVE, SUITE A, MIDDLETOWN, DE 19709
Branschkoder
Pharmaceutical Preparations, 2834

AI Kvalitetsanalys

Bransch
Biotechnology
SSL/HTTPS
Säker
Professionell E-post
Ja
Kontakt E-post
bd@zymeworks.com

🌟 Liknande Pålitliga Företag

Metagenomi, Inc.

Metagenomi, Inc. logo
74/100 · Pålitlig

Metagenomi is an in vivo genome editing company creating curative genetic medicines using proprietary technologies. They leverage metagenomics to discover editing tools potentially capable of correcting any type of genetic mutation. The company focuses on diseases with well-understood biology and clear regulatory pathways, and intends to expand their pipeline through genetic editing capabilities.

5959 HORTON STREET, USA
Visa profil

ARCTICZYMES TECHNOLOGIES ASA

ARCTICZYMES TECHNOLOGIES ASA logo
80/100 · Mycket Pålitlig

ArcticZymes Technologies är ett bioteknikföretag specialiserat på utveckling och produktion av enzymer. De erbjuder nukleaser för bioproduktion och molekylär diagnostik, inklusive Salt Active Nucleases (SAN). Företaget är känt för sina polymeraser och enzymer som används inom forsknings- och industriella applikationer.

Sykehusvegen 23, Norway
Visa profil

ACD PHARMACEUTICALS AS

ACD PHARMACEUTICALS AS logo
80/100 · Mycket Pålitlig

ACD Pharma is a Norwegian R&D company developing biocontrol products based on bacteriophages, focusing on combating harmful bacteria in animals and humans. They launched Custus®YRS, the world's first bacteriophage product for aquaculture. They collaborate with pharmaceutical and scientific teams to fight antibiotic resistance, extending their advancements across sectors.

Lofoten Bio Centre, Norway10 anställda
Visa profil